ライフサイエンスコーパス: spinal fusion

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 H occurs in a subset of children who undergo spinal fusion.

2 tance of anaerobic bacteria in SSI following spinal fusion.

3 erior, posterior, or both anterior/posterior spinal fusion.

4 One death occurred 10 days following spinal fusion.

5 surgery with extensive osseous involvement (spinal fusion and craniofacial reconstruction).

6 (BMP2) and BMP7 are FDA approved to promote spinal fusion and fracture healing, respectively, and th

7 amiliar with the imaging features of typical spinal fusion and many of the complications seen in pati

8 There were two deaths (7%), one following spinal fusion and the other following appendectomy at an

9 d clinically to induce new bone formation in spinal fusions and long bone non-union fractures.

10 recombinant BMPs promote healing of bone in spinal fusions and, in some cases, of open fractures, bu

11 by sex, frequency of progression to complete spinal fusion, and association between hip arthritis and

12 3 hysterectomies, 3 vasectomies, and 1 each spinal fusion, appendectomy, eye enucleation, hernia rep

13 for the year 2006 among patients undergoing spinal fusion by BMP use status, no differences were see

14 one (ADH) is elevated in patients undergoing spinal fusion, especially in those who have clinical evi

15 intervertebral discs from 38 patients during spinal fusion for chronic back pain.

16 terature regarding long-term follow-up after spinal fusion for patients with adolescent idiopathic sc

17 crews affixed to titanium alloy rods) lumbar spinal fusion in addition to decompressive laminectomy i

18 tors has important implications for surgical spinal fusions in humans.

19 Lumbar spinal fusion is a commonly performed procedure, and, de

20 protein was used in approximately 25% of all spinal fusions nationally in 2006, with use associated w

21 (72%) in patients admitted after surgery for spinal fusion or craniofacial reconstruction.

22 es the risk for postoperative infections for spinal fusion patients.

23 ates of use of BMP among patients undergoing spinal fusion procedures are examined along with complic

24 cohort study of 328,468 patients undergoing spinal fusion procedures from 2002-2006 identified from

25 In spinal fusion, rhBMP-2 has no proven clinical advantage

26 l interventions (eg, tendon lengthenings and spinal fusion), steroid use, and extent of respiratory s

27 Risk factors associated with prone spinal fusion surgery and ischemic optic neuropathy iden

28 hemic optic neuropathy associated with prone spinal fusion surgery that are extrinsic to the patient

29 Given the recent advances in spinal fusion surgery, it is important that radiologists

30 e of pneumocephalus and pneumorrhachis after spinal fusion surgery.

31 t of pneumocephalus and pneumorrhachis after spinal fusion surgery.

32 use of bone-morphogenetic proteins (BMPs) in spinal fusion surgery.

33 nstrated generally satisfactory results with spinal fusion surgery.

34 ted with ischemic optic neuropathy and prone spinal fusion surgery.

35 I spondylolisthesis, the addition of lumbar spinal fusion to laminectomy was associated with slightl

36 An animal model of spinal fusion using osteoinductive growth factors has im

37 Complete spinal fusion was observed in 27.9% of patients with AS

38 of surgical-site infections (SSI) following spinal fusion was retrospectively studied.

39 BMP-2) is used as a bone graft substitute in spinal fusion, which unites (fuses) bones in the spine.

40 who fail conservative management may undergo spinal fusion with pedicle screw instrumentation.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。